Sedation for Upper Gastrointestinal Endoscopy in Pediatric Patients

Comparative Study Between Propofol-Ketamine Combination and Dexmedetomidine-Ketamine Combination for Sedation in Upper Gastrointestinal Endoscopy in Paediatric Patients.

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02863861

Enrollment

120

Registered

2016-08-11

Start date

2016-09-30

Completion date

Unknown

Last updated

2016-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Gastrointestinal Endoscopy

Keywords

Sedation, Pediatric Patients

Brief summary

The purpose of this study is to compere between Propofol-Ketamine combination and Dexmedetomidine-Ketamine combination for sedation in upper gastrointestinal endoscopy in paediatric patients.

Interventions

DRUGDexmedetomidine-ketamine

DRUGpropofol-ketamine

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender

ALL

Age

2 Years to 7 Years

Healthy volunteers

Yes

Inclusion criteria

* American Society of Anesthesiologists ASA I-II patients aging 2-7 years.

Exclusion criteria

known allergy to any of the study drugs, significant cardiovascular disease vomiting.

Design outcomes

Primary

Measure	Time frame
length of stay in PACU	three months

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026